Reaction
Pyuria reporting signals
As of the last recalculation, Pyuria appears in 974 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 22.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 12 | 22.1 | 22.1 |
| Anti-Thymocyte Globulin (Rabbit) | 8 | 21.4 | 21.4 |
| Gentamicin | 11 | 18.2 | 18.2 |
| Gentamicin Sulfate | 12 | 16.4 | 16.4 |
| Valganciclovir | 14 | 16.1 | 16.1 |
| Valganciclovir Hydrochloride | 14 | 16.1 | 16.1 |
| Carboxymethylcellulose Sodium | 7 | 16.0 | 16.0 |
| Piperacillin Sodium And Tazobactam Sodium | 14 | 15.5 | 15.5 |
| Ceftriaxone Sodium | 27 | 15.4 | 15.5 |
| Everolimus Tablets | 11 | 14.2 | 14.2 |
| Ceftriaxone | 21 | 14.0 | 14.0 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 12.4 | 12.4 |
| Dapagliflozin | 16 | 11.0 | 11.0 |
| Lapatinib | 6 | 8.3 | 8.3 |
| Voclosporin | 3 | 7.4 | 7.4 |
| Polatuzumab Vedotin | 3 | 6.6 | 6.6 |